“Indian Authorities Approve New Australian Hepatitis B Vaccine”

Return to Vaccination News Home Page __» Right-click to "open in new window"

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

A third-generation hepatitis B vaccine, developed by Biotech SciGen of Australia, has received approval from India’s Genetic Engineering Advisory Committee. The company is now planning clinical trials in India for registration purposes. After just a year of clinical trials, the drug will enter the Indian market, if the Drug Controller General of India approves.

Return to Vaccination News Home Page __» Right-click to "open in new window"

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.